Catherine Matthes

Catherine Matthes has an extensive work experience in various leadership roles. Catherine is currently serving as the Chief Financial Officer at InterVene, Inc. Prior to this, they held the same position at CuriMeta, Inc., where they contributed to advancing scientific research and clinical challenges in healthcare. Catherine also worked as the Chief Financial Officer at Euphrates Vascular, where they played a key role in the development of innovative medical devices.

Before their roles at CuriMeta and Euphrates Vascular, Catherine Matthes founded and managed MedFINiti LLC, a company dedicated to providing financial and management services in the medical field. Catherine also served as the Chief Financial Officer at Veniti, a medical device company focused on treating vein diseases, and Galera Therapeutics, a life science company specializing in drugs for the treatment of oral mucositis.

Additionally, Catherine Matthes worked as an Advisor at Confluence Life Sciences, where they played a pivotal role in the pharmaceutical development of novel treatments. Catherine also held a senior position at Solae, LLC, where they were responsible for mergers and acquisitions and new business development in the food industry.

Catherine Matthes' career began in 2001 when they became the Chief Financial Officer at Kereos, Inc., a life science company working on targeted cancer imaging and treatment. During their tenure, they oversaw finance, accounting, human resources, IT, risk management, and office administration activities.

With their diverse experiences in the healthcare, medical device, pharmaceutical, and food industries, Catherine Matthes has demonstrated their expertise in strategic leadership and financial management throughout their career.

Catherine Matthes earned a Bachelor of Science in Business Administration (BSBA) with a major in Accounting from the University of Missouri-Saint Louis. Catherine attended the university from 1983 to 1987.